pI: 5.9465 |
Length (AA): 260 |
MW (Da): 29056 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_129517)
Species | Accession | Gene Product |
---|---|---|
Candida albicans | CaO19.3273 | similar to S. cerevisiae YCR059C involved in regulation of amino acid metabolsm |
Candida albicans | CaO19.3274 | general amino acid control pathway |
Candida albicans | CaO19.10784 | general amino acid control pathway |
Candida albicans | CaO19.10783 | similar to S. cerevisiae YCR059C involved in regulation of amino acid metabolsm |
Caenorhabditis elegans | CELE_Y52B11A.2 | Protein Y52B11A.2, isoform B |
Cryptosporidium parvum | cgd2_2430 | ximpact ortholog conserved protein seen in bacteria and eukaryotes |
Dictyostelium discoideum | DDB_G0287757 | hypothetical protein |
Echinococcus granulosus | EgrG_000983600 | protein IMPACT |
Entamoeba histolytica | EHI_013300 | hypothetical protein, conserved |
Echinococcus multilocularis | EmuJ_000983600 | protein IMPACT |
Giardia lamblia | GL50803_15984 | Impact-like protein |
Homo sapiens | ENSG00000154059 | impact RWD domain protein |
Leishmania braziliensis | LbrM.35.5190 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_365170.1 | Uncharacterized protein family UPF0029, putative |
Leishmania infantum | LinJ.36.5170 | hypothetical protein, conserved |
Leishmania major | LmjF.36.4940 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.36.4940 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_15784 | hypothetical protein |
Loa Loa (eye worm) | LOAG_14972 | hypothetical protein |
Mus musculus | ENSMUSG00000024423 | impact, RWD domain protein |
Onchocerca volvulus | OVOC3400 |
|
Saccharomyces cerevisiae | YCR059C | Yih1p |
Schistosoma japonicum | Sjp_0135010 | IPR001498,Protein of unknown function UPF0029;IPR006575,RWD,domain-containing |
Schistosoma japonicum | Sjp_0210280 | Protein IMPACT-A, putative |
Schistosoma japonicum | Sjp_0057040 | IPR001498,Protein of unknown function UPF0029;IPR006575,RWD,domain-containing |
Schistosoma japonicum | Sjp_0119610 | IPR006575,RWD,domain-containing |
Schistosoma mansoni | Smp_029370 | hypothetical protein |
Schmidtea mediterranea | mk4.006384.00 | Protein IMPACT homolog |
Trypanosoma brucei gambiense | Tbg972.11.12300 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.11.10970 | RWD domain/Uncharacterized protein family UPF0029, putative |
Trypanosoma congolense | TcIL3000.11.11690 | RWD domain/Uncharacterized protein family UPF0029, putative |
Trypanosoma cruzi | TcCLB.508269.10 | RWD domain/Uncharacterized protein family UPF0029, putative |
Trypanosoma cruzi | TcCLB.503971.20 | RWD domain/Uncharacterized protein family UPF0029, putative |
Trichomonas vaginalis | TVAG_291410 | impact, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.2750 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.2750 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.2750 this record | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb11.01.2750 this record | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in procyclic forms . | References: | 21363968 | |
cell proliferation (GO:0008283) | increased (PATO:0000470) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | increased cell proliferation (significant gain of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
1 literature reference was collected for this gene.